INTEGRA Biosciences is inviting labs to leave manual pipetting behind and take their first steps into effortless automation ...

Integra Biosciences is challenging laboratories to move beyond manual pipetting with its Lab Evolution competition for 2026.

Conventional treatment options for patients diagnosed with solid cancers or autoimmune diseases are often limited or ineffective. Developing alternative treatments for these challenging conditions ...

QIAGEN uses INTEGRA’s handheld and benchtop electronic liquid handling technologies to expedite and standardize nucleic acid isolation and PCR setup methods in its Genomic Services division. This ...